Myostine YK-11

YK-11 is a unique and potent compound that occupies a distinct niche in the performance enhancement landscape. It is a steroidal compound that functions as a Selective Androgen Receptor Modulator (SARM).

This dual nature sets it apart: its steroidal backbone suggests significant anabolic potency, while its SARM-like selectivity aims to direct this action. However, its most defining and debated characteristic is its function as a partial agonist of the androgen receptor that also demonstrates myostatin-inhibiting properties.

Myostatin is a protein that acts as a natural limiter of muscle growth. By inhibiting this “brake,” YK-11 theoretically offers a unique pathway to muscle growth beyond standard receptor activation, making it a compound of intense interest and speculation for extreme muscle accrual.

YK-11 Benefits

The proposed mechanism of YK-11 suggests a theoretical potential for dramatic, high-quality muscle growth.

Potential for Exceptional, Dense Muscle Growth

As a steroidal SARM with myostatin inhibition, YK-11 is believed by users to promote rapid and substantial gains in lean mass. The gains are often described as dense, hard, and of high quality, with a pronounced increase in muscle density and separation.

Significant Increases in Strength and Power

The strong androgen receptor activation directly translates to the weight room. Users report powerful and rapid improvements in strength, allowing for consistent progression on heavy compound lifts.

Enhanced Muscle Hardness and Vascularity

The compound promotes a very dry, hard, and grainy look. Muscles appear tightly packed, highly striated, and exceptionally vascular, contributing to a stage-ready physique even in the off-season.

Myostatin Inhibition

A Unique Mechanism: This is the cornerstone of YK-11’s appeal. By potentially lowering levels of myostatin, the body’s primary negative regulator of muscle size, it may allow for muscle growth beyond what is typically constrained by one’s genetic ceiling. It’s important to note that robust human clinical evidence for this effect is lacking.

YK-11 Side Effects

The potent and novel nature of YK-11 comes with a severe and demanding side effect profile that cannot be overstated.

Extreme Suppression of Natural Testosterone

YK-11 is profoundly suppressive, likely exceeding the suppression caused by traditional non-steroidal SARMs. Its steroidal nature and strong receptor binding lead to a near-total shutdown of endogenous testosterone production. A powerful, multi-faceted Post-Cycle Therapy (PCT) is not just recommended; it is medically critical for recovery.

High Risk of Estrogenic and Progestogenic Side Effects

Due to its steroidal structure, YK-11 may carry a risk of interacting with estrogen and progesterone receptors, not just androgen receptors. This significantly increases the risk of gynecomastia, severe water retention, and potential progestogenic side effects, making the use of ancillary medications like Aromatase Inhibitors (AIs) and dopamine agonists (e.g., Cabergoline) a serious consideration for many users.

Severe Negative Impact on Lipid Profiles

YK-11 aggressively crushes HDL (“good”) cholesterol and elevates LDL, posing an extreme and immediate risk to cardiovascular health. This requires the most diligent nutritional and supplemental support.

Pronounced Liver Stress

As an oral steroidal compound, it is highly stressful to the liver. Significant elevations in ALT and AST are expected. Cycle support with robust hepatoprotectants like TUDCA is mandatory, and cycle length must be kept short.

Joint Pain and Dryness

A frequently reported and paradoxical side effect. Despite promoting muscle growth, many users experience intense joint pain, dryness, and “wooden” feeling in tendons. This is thought to be due to its potent drying effect and possible impact on collagen synthesis, making joints vulnerable under heavy loads.

Hair Loss (Androgenic Alopecia)

Given its potent androgenic activity, it poses a high risk of accelerating male pattern hair loss in those genetically predisposed.

How to Take YK-11

YK-11 demands the highest level of caution, research, and preparation. It is not a beginner compound.

Cycle Length

Extremely short cycles are mandatory. A cycle should not exceed 6 to 8 weeks due to its severe hepatic and suppressive toxicity. Longer use is dangerous and counterproductive.

Dosage for Men

5 mg to 10 mg per day, taken orally. It is often split into two doses (e.g., 5 mg twice daily) due to a suggested shorter half-life. Even 5 mg per day is a potent dose. Starting at this minimum and assessing tolerance for the first week is the only prudent approach. Injectable forms are discussed anecdotally but introduce further complexities.

Dosage for Women

Absolutely not recommended and considered dangerous. The virilization risk is extreme and likely irreversible.

Best Stacks with YK-11

YK-11 is used as a potent additive in advanced stacks, often to break plateaus.

The Extreme Mass Stack

YK-11 and a Testosterone Base. This is a common and logical stack in advanced circles. A testosterone ester (like Testosterone Enanthate) provides a strong androgen base and mitigates the total suppression from YK-11, while YK-11 adds its unique myostatin-inhibiting and hardening effects. This is a full steroid cycle, not a SARM cycle.

The Hardening & Strength Stack

YK-11 + RAD-140. This oral stack combines two of the strongest and hardest compounds. It is immensely taxing on the liver, lipids, and HPTA, and should only be considered by very experienced users with exhaustive support and post-cycle plans.

The Recomposition Stack

YK-11 + Cardarine (GW-501516). Adding Cardarine may help counteract some negative lipid effects and provide endurance, while YK-11 drives muscle hardness and fat-free mass.

YK-11 Cycle Guidelines

This table outlines a maximal 6-week protocol for an experienced male researcher with all support supplements in place. This is a high-risk protocol.

Results to Expect with YK-11

A YK-11 cycle, if survived with health intact, may produce noticeable hardening and density.

The most consistent reported result is a significant increase in muscle hardness, vascularity, and density, creating a dry, grainy look.

Strength gains can be rapid. However, the actual hyperplasia (new muscle cell growth) claimed from myostatin inhibition is theoretical and unproven in humans. Much of the weight gain may be from intramuscular fluid and other tissues. 

The joint pain often limits training capacity. The results are highly individual and come at an extraordinary cost to overall health, making it one of the most controversial and risk-laden compounds in use.

Compliance and Security

• As a steroidal SARM, YK-11 is unequivocally an unapproved new drug under Canada’s Food and Drugs Act.
• Its status is complex. While not explicitly listed, its steroidal nature could potentially bring it under the analog or scheduling provisions of the CDSA.
• It is strictly prohibited by the World Anti-Doping Agency (WADA) as both an anabolic agent and a myostatin inhibitor.